AU5874690A - Octreotide-pamoate - Google Patents

Octreotide-pamoate

Info

Publication number: AU5874690A
Authority: AU; Australia
Prior art keywords: octreotide; pamoate
Prior art date: 1989-07-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU58746/90A

Other versions

AU641407B2 (en

Inventor

David Bodmer

Jones Wing Fong

Thomas Kissel

Hawkins Valliant Maulding

Oskar Nagele

Jane Edna Pearson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Novartis AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-07

Filing date

1990-07-05

Publication date

1991-01-10

1990-07-05 Application filed by Novartis AG filed Critical Novartis AG

1991-01-10 Publication of AU5874690A publication Critical patent/AU5874690A/en

1993-09-23 Application granted granted Critical

1993-09-23 Publication of AU641407B2 publication Critical patent/AU641407B2/en

1997-10-16 Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.

2010-07-05 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AU58746/90A 1989-07-07 1990-07-05 Octreotide-pamoate Expired AU641407B2 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US37702389A	1989-07-07	1989-07-07
US41134789A	1989-09-22	1989-09-22
US411347		1989-09-22
US377023		1989-09-22

Related Child Applications (2)

Application Number	Title	Priority Date	Filing Date
AU41986/93A Division AU663388B2 (en)	1989-07-07	1993-07-15	Sustained release formulations
AU41985/93A Division AU662825B2 (en)	1989-07-07	1993-07-15	Process for the production of microparticles

Publications (2)

Publication Number	Publication Date
AU5874690A true AU5874690A (en)	1991-01-10
AU641407B2 AU641407B2 (en)	1993-09-23

Family

ID=27007654

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU58746/90A Expired AU641407B2 (en)	1989-07-07	1990-07-05	Octreotide-pamoate
AU23321/95A Expired AU687553B2 (en)	1989-07-07	1995-06-29	Process for the production of microparticles

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU23321/95A Expired AU687553B2 (en)	1989-07-07	1995-06-29	Process for the production of microparticles

Country Status (27)

Country	Link
JP (5)	JPH0832624B2 (en)
KR (2)	KR100303681B1 (en)
AT (1)	AT406225B (en)
AU (2)	AU641407B2 (en)
BE (1)	BE1004486A3 (en)
CA (1)	CA2020477C (en)
CH (1)	CH685230A5 (en)
CY (1)	CY1965A (en)
DE (2)	DE4021517B4 (en)
DK (1)	DK175849B1 (en)
FI (3)	FI108611B (en)
FR (1)	FR2649319A1 (en)
GB (2)	GB2234896B (en)
GR (1)	GR1001121B (en)
HK (2)	HK97695A (en)
HU (2)	HU221294B1 (en)
IE (2)	IE64411B1 (en)
IL (3)	IL131881A (en)
IT (1)	IT1241460B (en)
LU (1)	LU87764A1 (en)
MY (1)	MY106722A (en)
NL (1)	NL195027C (en)
NO (2)	NO302928B1 (en)
NZ (1)	NZ234384A (en)
PT (1)	PT94628B (en)
SE (1)	SE512992C2 (en)
SG (1)	SG26416G (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4990336A (en) *	1989-02-08	1991-02-05	Biosearch, Inc.	Sustained release dosage form
YU48420B (en) *	1991-03-25	1998-07-10	Hoechst Aktiengesellschaft	PROCEDURE FOR OBTAINING BIOLOGICAL DEGRADABLE MICROPARTICLES WITH LONG TERM ACTION
CH683149A5 (en) *	1991-07-22	1994-01-31	Debio Rech Pharma Sa	Process for the preparation of microspheres of a biodegradable polymeric material.
US5876452A (en) *	1992-02-14	1999-03-02	Board Of Regents, University Of Texas System	Biodegradable implant
US6013853A (en) *	1992-02-14	2000-01-11	The University Of Texas System	Continuous release polymeric implant carrier
DE4218510A1 (en) *	1992-06-02	1993-12-09	Pharmatech Gmbh	Process for the preparation of biodegradable polyesters
AU4198793A (en) †	1992-07-24	1994-01-27	Takeda Chemical Industries Ltd.	Microparticle preparation and production thereof
EP0626170A3 (en) *	1993-05-10	1996-03-27	Sandoz Ltd	Stabilization of pharmacoligically active compounds in controlled release compositions.
US5603960A (en) *	1993-05-25	1997-02-18	O'hagan; Derek T.	Preparation of microparticles and method of immunization
GB9310781D0 (en) *	1993-05-25	1993-07-14	Davis Stanley S	Preparation of microparticles
DE69434258T2 (en)	1993-11-19	2006-01-19	Janssen Pharmaceutica N.V.	MICRO-CAPSULATED 1,2-BENZAZOLE
ATE192334T1 (en)	1995-11-09	2000-05-15	Microbiological Res Authority	MICRO-ENCAPSULED DNA FOR VACCINATION AND GENE THERAPY
US6270795B1 (en)	1995-11-09	2001-08-07	Microbiological Research Authority	Method of making microencapsulated DNA for vaccination and gene therapy
DE19545257A1 (en)	1995-11-24	1997-06-19	Schering Ag	Process for the production of morphologically uniform microcapsules and microcapsules produced by this process
US5817343A (en) *	1996-05-14	1998-10-06	Alkermes, Inc.	Method for fabricating polymer-based controlled-release devices
US5968895A (en) *	1996-12-11	1999-10-19	Praecis Pharmaceuticals, Inc.	Pharmaceutical formulations for sustained drug delivery
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
GB9810236D0 (en) *	1998-05-13	1998-07-08	Microbiological Res Authority	Improvements relating to encapsulation of bioactive agents
US6632457B1 (en) *	1998-08-14	2003-10-14	Incept Llc	Composite hydrogel drug delivery systems
US7107268B1 (en)	1998-11-12	2006-09-12	Printable Technologies, Inc.	Centralized system and method for managing enterprise operations
US6226656B1 (en)	1998-11-12	2001-05-01	Sourcefinder, Inc.	System and method for creating, generating and processing user-defined generic specs
US6204308B1 (en)	1999-03-01	2001-03-20	Novartis Ag	Organic compounds
EP1044683A1 (en)	1999-04-15	2000-10-18	Debio Recherche Pharmaceutique S.A.	One-step dispersion method for the microencapsulation of water soluble substances
US6461631B1 (en) *	1999-11-16	2002-10-08	Atrix Laboratories, Inc.	Biodegradable polymer composition
KR100392501B1 (en) *	2000-06-28	2003-07-22	동국제약 주식회사	Preparation Method for Sustained Release Microparticles by Multiple Emulsion Method and Micropartic les Thereof
US6824822B2 (en) *	2001-08-31	2004-11-30	Alkermes Controlled Therapeutics Inc. Ii	Residual solvent extraction method and microparticles produced thereby
CA2432904C (en)	2000-12-21	2007-09-11	Nektar Therapeutics	Induced phase transition method for the production of microparticles containing hydrophobic active agents
US20040097419A1 (en) *	2002-11-19	2004-05-20	Holger Petersen	Organic compounds
AR044852A1 (en) *	2003-06-24	2005-10-05	Novartis Ag	A PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION THAT INCLUDES A SOMATOSTATINE ANALOG
WO2005007122A2 (en) *	2003-07-18	2005-01-27	Oakwood Laboratories, L.L.C.	Polymer stabilization
MY158342A (en) *	2003-11-14	2016-09-30	Novartis Ag	Pharmaceutical composition
CA2557397A1 (en) *	2004-02-26	2005-09-09	Japan Science And Technology Agency	Protein drug sustained-release microparticle preparation for injection and process for producing the same
DE102004053373A1 (en) *	2004-11-02	2006-05-04	Justus-Liebig-Universität Giessen	Invention relating to nano / meso-fiber anisometric particles in the form of nano / meso-fiber tubes, cables and their curved or branched modifications
KR100741867B1 (en) *	2005-07-05	2007-07-24	전북대학교산학협력단	Method of Preparation of Double Layered Microspheres Using Oil-in-water and Solvent Evaporation
EP1968549B1 (en) *	2005-12-22	2014-05-14	Novartis AG	Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
KR100816065B1 (en)	2006-11-27	2008-03-24	동국제약 주식회사	Method for preparing sustained release microcapsules with excellent initial release control characteristics and microcapsules prepared by the same
KR101921800B1 (en)	2008-01-30	2018-11-23	노파르티스 아게	Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
USRE49251E1 (en)	2010-01-04	2022-10-18	Mapi Pharma Ltd.	Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
AU2011308897B2 (en) *	2010-09-30	2015-06-18	Evonik Corporation	Emulsion method for preparing low residual solvent microparticles
AU2011308893B2 (en) *	2010-09-30	2015-04-23	Evonik Corporation	Method for removing residual organic solvent from microparticles
TW201605488A (en)	2013-10-15	2016-02-16	大塚製藥股份有限公司	Drug for preventing and/or treating polycystic kidney disease
KR102464650B1 (en)	2016-05-03	2022-11-10	엘에스일렉트릭(주)	Current limiting device of circuit breaker
US12097292B2 (en)	2016-08-28	2024-09-24	Mapi Pharma Ltd.	Process for preparing microparticles containing glatiramer acetate
EP3600553A4 (en)	2017-03-26	2020-09-02	Mapi Pharma Ltd.	GLATIRAMER DEPOT SYSTEMS FOR TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3773919A (en) *	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
CH644768A5 (en) *	1977-08-25	1984-08-31	Sandoz Ag	METHOD FOR PRODUCING MICROBALLS.
US4622244A (en) *	1979-09-04	1986-11-11	The Washington University	Process for preparation of microcapsules
US4293539A (en) *	1979-09-12	1981-10-06	Eli Lilly And Company	Controlled release formulations and method of treatment
CY1327A (en) *	1979-11-27	1986-06-27	Sandoz Ag	Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
US4389330A (en) *	1980-10-06	1983-06-21	Stolle Research And Development Corporation	Microencapsulation process
PH19942A (en) *	1980-11-18	1986-08-14	Sintex Inc	Microencapsulation of water soluble polypeptides
US4675189A (en) *	1980-11-18	1987-06-23	Syntex (U.S.A.) Inc.	Microencapsulation of water soluble active polypeptides
IE52535B1 (en) *	1981-02-16	1987-12-09	Ici Plc	Continuous release pharmaceutical compositions
EP0092918B1 (en) *	1982-04-22	1988-10-19	Imperial Chemical Industries Plc	Continuous release formulations
CH656884A5 (en) *	1983-08-26	1986-07-31	Sandoz Ag	POLYOLESTERS, THEIR PRODUCTION AND USE.
US4485101A (en) *	1983-10-11	1984-11-27	Administrators Of The Tulane Educational Fund	Peptides
JPH0657658B2 (en) *	1985-04-11	1994-08-03	住友製薬株式会社	Sustained release formulation
JPS60100516A (en) *	1983-11-04	1985-06-04	Takeda Chem Ind Ltd	Preparation of sustained release microcapsule
GB8331158D0 (en) *	1983-11-22	1983-12-29	British Telecomm	Metal/semiconductor deposition
JPS60181029A (en) *	1984-02-29	1985-09-14	Toyo Jozo Co Ltd	Preparation of sustained release preparation
CH660302A5 (en) *	1984-10-17	1987-04-15	Debiopharm Sa	HETEROGENEOUS PHASE MICRO-ENCAPSULATION PROCESS OF WATER-SOLUBLE DRUG SUBSTANCES.
DE3678308D1 (en) *	1985-02-07	1991-05-02	Takeda Chemical Industries Ltd	METHOD FOR PRODUCING MICROCAPSULES.
US4725577A (en) *	1985-04-25	1988-02-16	Administrators Of The Tulane Educational Fund	Biologically active lysine containing octapeptides
CH665558A5 (en) *	1985-10-09	1988-05-31	Debiopharm Sa	Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
JP2539789B2 (en) *	1986-03-06	1996-10-02	日本原子力研究所	Process for producing sustained-release drug complex composed of polylactone
GB2193891B (en) *	1986-08-18	1990-07-25	Sandoz Ltd	Nasal pharmaceutical composition containing a somatostatin anologue.
JPH0725689B2 (en) *	1986-10-07	1995-03-22	中外製薬株式会社	Sustained-release preparation containing granulocyte colony-stimulating factor
GB2209937B (en) *	1987-09-21	1991-07-03	Depiopharm S A	Water insoluble polypeptides
CH672887A5 (en) *	1987-10-14	1990-01-15	Debiopharm Sa
DE3738228A1 (en) *	1987-11-11	1989-05-24	Hoechst Ag	METHOD FOR PRODUCING BIODEGRADABLE MICRO-CAPSULES OF WATER-SOLUBLE PEPTIDES AND PROTEINS AND MICRO-CAPSULES OBTAINED BY THIS PROCESS
JP2653255B2 (en) *	1990-02-13	1997-09-17	武田薬品工業株式会社	Long-term sustained release microcapsules

1990
- 1990-06-25 HU HU974/90A patent/HU221294B1/en unknown
- 1990-07-03 GB GB9014704A patent/GB2234896B/en not_active Expired - Lifetime
- 1990-07-03 SG SG1995907374A patent/SG26416G/en unknown
- 1990-07-05 AU AU58746/90A patent/AU641407B2/en not_active Expired
- 1990-07-05 NL NL9001537A patent/NL195027C/en not_active IP Right Cessation
- 1990-07-05 FR FR9008718A patent/FR2649319A1/en active Granted
- 1990-07-05 DK DK199001625A patent/DK175849B1/en not_active IP Right Cessation
- 1990-07-05 IE IE43894A patent/IE64411B1/en not_active IP Right Cessation
- 1990-07-05 CH CH2249/90A patent/CH685230A5/en not_active IP Right Cessation
- 1990-07-05 SE SE9002364A patent/SE512992C2/en not_active IP Right Cessation
- 1990-07-05 IE IE243590A patent/IE64216B1/en not_active IP Right Cessation
- 1990-07-05 IL IL13188190A patent/IL131881A/en active IP Right Grant
- 1990-07-05 IL IL9498390A patent/IL94983A/en active IP Right Grant
- 1990-07-05 GR GR900100513A patent/GR1001121B/en not_active IP Right Cessation
- 1990-07-05 BE BE9000693A patent/BE1004486A3/en not_active IP Right Cessation
- 1990-07-05 NO NO903001A patent/NO302928B1/en not_active IP Right Cessation
- 1990-07-05 IT IT48113A patent/IT1241460B/en active IP Right Grant
- 1990-07-05 NZ NZ234384A patent/NZ234384A/en unknown
- 1990-07-05 CA CA002020477A patent/CA2020477C/en not_active Expired - Lifetime
- 1990-07-05 IL IL13188090A patent/IL131880A/en active IP Right Grant
- 1990-07-06 JP JP2177665A patent/JPH0832624B2/en not_active Expired - Lifetime
- 1990-07-06 AT AT0144090A patent/AT406225B/en not_active IP Right Cessation
- 1990-07-06 KR KR1019900010224A patent/KR100303681B1/en not_active IP Right Cessation
- 1990-07-06 FI FI903429A patent/FI108611B/en active IP Right Grant
- 1990-07-06 DE DE4021517A patent/DE4021517B4/en not_active Expired - Lifetime
- 1990-07-06 DE DE4042752A patent/DE4042752B4/en not_active Expired - Lifetime
- 1990-07-06 PT PT94628A patent/PT94628B/en not_active IP Right Cessation
- 1990-07-06 MY MYPI90001133A patent/MY106722A/en unknown
- 1990-07-09 LU LU87764A patent/LU87764A1/en unknown
1993
- 1993-03-25 GB GB9306204A patent/GB2265311B/en not_active Expired - Lifetime
1995
- 1995-04-18 JP JP7116486A patent/JP2931773B2/en not_active Expired - Lifetime
- 1995-04-18 JP JP7116539A patent/JPH07309897A/en active Pending
- 1995-06-15 HK HK97695A patent/HK97695A/en not_active IP Right Cessation
- 1995-06-28 HU HU95P/P00523P patent/HU211602A9/en unknown
- 1995-06-29 AU AU23321/95A patent/AU687553B2/en not_active Expired
- 1995-08-15 JP JP7228646A patent/JPH08198771A/en active Pending
1996
- 1996-10-31 HK HK197496A patent/HK197496A/en not_active IP Right Cessation
1997
- 1997-07-04 CY CY196597A patent/CY1965A/en unknown
1998
- 1998-08-26 NO NO19983923A patent/NO320444B1/en unknown
1999
- 1999-09-14 KR KR1019990039209A patent/KR100442931B1/en not_active Expired - Lifetime
2000
- 2000-01-12 FI FI20000059A patent/FI109543B/en active
- 2000-01-12 FI FI20000060A patent/FI109334B/en active
2001
- 2001-01-15 JP JP2001006486A patent/JP2001233897A/en active Pending

Also Published As

Publication number	Publication date
SG26416G (en)	1995-09-01
JP2931773B2 (en)	1999-08-09
NO983923D0 (en)	1998-08-26
IL131880A (en)	2001-12-23
JPH08198771A (en)	1996-08-06
KR100303681B1 (en)	2002-05-16
FI20000060L (en)	2000-01-12
NO320444B1 (en)	2005-12-05
JPH0832624B2 (en)	1996-03-29
AU687553B2 (en)	1998-02-26
HU903974D0 (en)	1990-11-28
FI108611B (en)	2002-02-28
FI903429A0 (en)	1990-07-06
PT94628B (en)	1997-06-30
FR2649319A1 (en)	1991-01-11
SE512992C2 (en)	2000-06-12
KR100442931B1 (en)	2004-08-02
DK175849B1 (en)	2005-03-29
IE902435A1 (en)	1991-02-13
FI20000059L (en)	2000-01-12
IL94983A0 (en)	1991-06-10
CA2020477C (en)	2000-11-21
HUT54037A (en)	1991-01-28
NL195027B (en)	2003-08-01
IE64216B1 (en)	1995-07-26
NL9001537A (en)	1991-02-01
NZ234384A (en)	1994-05-26
CH685230A5 (en)	1995-05-15
NO903001L (en)	1991-01-08
IE64411B1 (en)	1995-08-09
NL195027C (en)	2003-12-02
GR1001121B (en)	1993-04-28
KR910002430A (en)	1991-02-25
AU641407B2 (en)	1993-09-23
PT94628A (en)	1991-03-20
GB2234896B (en)	1994-01-19
IT1241460B (en)	1994-01-17
HU221294B1 (en)	2002-09-28
LU87764A1 (en)	1992-03-11
GB2265311B (en)	1994-02-09
BE1004486A3 (en)	1992-12-01
IT9048113A0 (en)	1990-07-05
AT406225B (en)	2000-03-27
IT9048113A1 (en)	1992-01-05
NO983923L (en)	1991-01-08
GR900100513A (en)	1991-12-10
ATA144090A (en)	1999-08-15
JP2001233897A (en)	2001-08-28
FI109543B (en)	2002-08-30
AU2332195A (en)	1995-09-07
FI109334B (en)	2002-07-15
GB2234896A (en)	1991-02-20
HK97695A (en)	1995-06-23
GB9014704D0 (en)	1990-08-22
FR2649319B1 (en)	1994-12-09
DE4021517B4 (en)	2009-04-09
MY106722A (en)	1995-07-31
IL94983A (en)	1999-08-17
SE9002364L (en)	1991-01-08
JPH0368511A (en)	1991-03-25
HK197496A (en)	1996-11-08
NO903001D0 (en)	1990-07-05
SE9002364D0 (en)	1990-07-05
GB2265311A (en)	1993-09-29
DK162590D0 (en)	1990-07-05
IL131881A (en)	2001-12-23
HU211602A9 (en)	1995-12-28
CA2020477A1 (en)	1991-01-08
DE4021517A1 (en)	1991-01-17
DE4042752B4 (en)	2009-05-07
JPH07309897A (en)	1995-11-28
CY1965A (en)	1997-07-04
GB9306204D0 (en)	1993-05-19
DK162590A (en)	1991-01-08
NO302928B1 (en)	1998-05-11
JPH07285853A (en)	1995-10-31

Publication	Publication Date	Title
AU5748990A (en)	1990-11-29	Venoscope
AU5874690A (en)	1991-01-10	Octreotide-pamoate
AU5348790A (en)	1990-11-05	Micro-multi-electrode arrangement
AU623795B2 (en)	1992-05-21	New substituted 1h-indazole-3-carboxamides
AU627080B2 (en)	1992-08-13	Sulphonylaminocarbonyltriazolinones
AU5064390A (en)	1990-09-13	Downcomer-tray assembly
AU623262B2 (en)	1992-05-07	Hydroxypropylamines
AU6673290A (en)	1991-05-23	Dipyridodiazepines
AU631622B2 (en)	1992-12-03	Snow-vehicle
AU6627590A (en)	1991-05-16	Doll-container
AU623780B2 (en)	1992-05-21	Chromanderivate
AU638279B2 (en)	1993-06-24	Water-actuated novelty
AU5583190A (en)	1990-11-22	Compounds
AU632104B2 (en)	1992-12-17	Substituted pyrimidin-6-ones(-6-thiones)
AU5782590A (en)	1991-01-03	Thioxotetrazolines
AU5336690A (en)	1990-10-09	Leg-guard
AU6839190A (en)	1991-06-27	Triazolylsulfonamides
AU5400390A (en)	1990-11-05	Substituted 1-phenylnaphthalenes
AU6260690A (en)	1991-03-28	Further novel alkanophenones
AU5195790A (en)	1990-10-09	Ligthead assembly
AU4944090A (en)	1990-08-13	Cryoelectrosynthesis
AU6268590A (en)	1991-04-18	Aminophosphinates
AU5915590A (en)	1991-01-24	Certain glyoxyl-cyclohexendiones
AU6217090A (en)	1991-03-14	Substituted amino-pyridines
AU5702590A (en)	1990-12-13	Recess former